niacin has been researched along with Arteriosclerosis in 144 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Colestipol is a safe, effective, cholesterol-lowering, bile-acid sequestrant that lowers low-density-lipoprotein (LDL) and total plasma cholesterol levels without consistently affecting high-density-lipoprotein (HDL) cholesterol levels." | 6.36 | Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. ( Glueck, CJ, 1982) |
| "The effect of several anti-atherogenic drugs (ticlopidine, nicotinic acid and etofibrate) on immune responses and immune complex anaphylaxis has been studied in mice." | 3.67 | Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes. ( Ojeda, G; Portolés, A; Portolés, MP; Rojo, JM, 1985) |
| " A total of 21% of the patients were unable to tolerate niacin owing to reversible side-effects, and 14% were unable to adhere to the niacin dosing regimen of three times daily." | 2.70 | Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes. ( Charles, MA; Kesala, RL; Lin, M; Pan, J; Van, J, 2002) |
| "Pravastatin was added to the drug regimen for those who needed to reduce LDL cholesterol to recommended levels." | 2.69 | Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease. ( Applegate, WB; Crouse, JR; Davis, KB; Egan, D; Elam, MB; Garg, R; Herd, JA; Hunninghake, DB; Johnson, WC; Kennedy, JW; Kostis, JB; Sheps, DS, 2000) |
| "The hypolipidemic effects of induracin, a new long-acting nicotinic acid dosage form based on the waxy matrix, and its tolerance were studied in 31 patients with Types IIa and IIb hyperlipoproteinemias in a 6-month blind crossover study." | 2.67 | [The use of Enduracin--a prolonged-action form of nicotinic acid--in correcting atherogenic dyslipidemias]. ( Akhmedzhanov, NM; Aronov, DM; Kiseleva, NG; Kiseleva, NS; Oganov, RG; Olfer'ev, AM; Perova, NV, 1993) |
| "Combination therapy for hyperlipidemia, especially combined hyperlipidemia, may have advantages over single drug therapy, affording better improvement in lipoprotein risk factors and possibly better prevention of atherothrombotic events." | 2.40 | Combination drug therapy for combined hyperlipidemia. ( Guyton, JR, 1999) |
| "Hypertriglyceridemia is a well-known risk factor for pancreatitis." | 2.38 | The triglyceride connection in atherosclerosis. ( Geurian, K; Pinson, JB; Weart, CW, 1992) |
| "Colestipol is a safe, effective, cholesterol-lowering, bile-acid sequestrant that lowers low-density-lipoprotein (LDL) and total plasma cholesterol levels without consistently affecting high-density-lipoprotein (HDL) cholesterol levels." | 2.36 | Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. ( Glueck, CJ, 1982) |
| "Terbutaline has also been reported to raise HDL cholesterol." | 1.27 | Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: therapeutic approaches to prevention of atherosclerosis. ( Glueck, CJ, 1985) |
| "Probucol has a sustained effect, additive to that of a lipid-lowering diet; it can reduce total serum cholesterol and cause xanthoma regression even in patients with receptor-defective homozygous familial hypercholesterolemia." | 1.27 | Medical management of hyperlipidemia and the role of probucol. ( Davignon, J, 1986) |
| "Prophylactic treatment of the hyperlipoproteinemia with the drugs niceritrol (Perycit) and beta-pyridylcarbinol (Ronicol) significantly reduced the elevated plasma cholesterol level and reduced the degree of atherosclerosis in the abdominal aorta and the coronary arteries." | 1.27 | [Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs]. ( Jacobsson, L, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 91 (63.19) | 18.7374 |
| 1990's | 24 (16.67) | 18.2507 |
| 2000's | 29 (20.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, J | 2 |
| Van, JT | 1 |
| Chan, E | 1 |
| Kesala, RL | 2 |
| Lin, M | 2 |
| Charles, MA | 2 |
| Samson, RH | 1 |
| Vinson, JA | 1 |
| Mandarano, MA | 1 |
| Shuta, DL | 1 |
| Bagchi, M | 1 |
| Bagchi, D | 1 |
| Hecht, HS | 1 |
| Harman, SM | 1 |
| Kuvin, JT | 1 |
| Karas, RH | 1 |
| SKURSKY, J | 1 |
| FEINBLATT, TM | 1 |
| FEINBLATT, HM | 1 |
| FERGUSON, EA | 1 |
| THOMPSON, LJ | 1 |
| PROCTOR, RC | 1 |
| BORENSKY, W | 1 |
| PASSERI, M | 1 |
| O'REILLY, PO | 1 |
| KEOGH, RP | 1 |
| DE SOLDATI, L | 1 |
| STRITZLER, G | 1 |
| BALASSANIAN, S | 1 |
| SHEARD, MH | 1 |
| COYNE, EP | 1 |
| HAMMONS, P | 1 |
| GALBRAITH, PA | 1 |
| PERRY, WF | 1 |
| BEAMISH, RE | 1 |
| FRIEDMAN, M | 1 |
| BYERS, SO | 1 |
| ALTSCHUL, R | 1 |
| SMART, TA | 1 |
| DE LA RIEGA, E | 1 |
| BURRIER, C | 1 |
| OST, CR | 1 |
| PALLUCCHINI, M | 1 |
| SECKFORT, H | 1 |
| ANDRES, E | 1 |
| LJUNGGREN, H | 1 |
| GRISSLER, J | 1 |
| PROBST, F | 1 |
| MOSSO, HE | 1 |
| DAVIS, OF | 1 |
| BECK, C | 1 |
| BERGAL, M | 1 |
| SLOAN, N | 1 |
| LEVINE, AJ | 1 |
| FLORIAN, HJ | 1 |
| FISKE, S | 1 |
| FOX, LP | 1 |
| CAVUSOGLU, M | 1 |
| GORODINS'KA, VIa | 1 |
| SIMON, IB | 1 |
| ILIESCU, CC | 1 |
| ILIESCU, M | 1 |
| ROMAN, L | 1 |
| IACOBINI, P | 1 |
| CONSTANTINESCU, S | 1 |
| NUTU, S | 1 |
| BARNETT, AJ | 1 |
| CARSON, VJ | 1 |
| WAHL, M | 1 |
| WEITZEL, G | 1 |
| WAHL, P | 1 |
| BUDDECKE, E | 1 |
| BURSTEIN, J | 1 |
| TELKKA, A | 1 |
| CLARKE, ET | 1 |
| KIMMERLING, HW | 1 |
| KNUECHEL, F | 1 |
| PARAMODIAZ, M | 1 |
| DIAZBALLESTEROS, F | 1 |
| SCHULZE, G | 1 |
| POLIVODA, H | 1 |
| KOESTERING, H | 1 |
| VASKO, J | 1 |
| YOUNGER, R | 1 |
| STEPHENSON, SE | 1 |
| MAZZEI, ES | 1 |
| MAZZEI, CM | 1 |
| IBRAHIM, MB | 1 |
| ARTEAGA, A | 1 |
| DIAZ, F | 1 |
| TORRES, MC | 2 |
| NUNEZ, I | 2 |
| LANGE, K | 1 |
| MAHL, M | 1 |
| MARKIEWICZ, M | 2 |
| ASTENGO, F | 1 |
| BESTAGNO, M | 1 |
| DOVGIALLO, GK | 1 |
| GULKO, IS | 1 |
| LUKOMSKII, PE | 1 |
| DENICOLA, P | 1 |
| FRANDOLI, G | 2 |
| GIBELLI, A | 2 |
| FERNANDEZBLANCO, E | 1 |
| DEFERNANDEZBLANCO, JF | 1 |
| AGUSTINARZENO, J | 1 |
| MOSELEY, V | 1 |
| GOTO, Y | 1 |
| NAKAMURA, H | 3 |
| KLEIN, L | 2 |
| ARTEAGALLONA, A | 1 |
| DIAZGREZ, F | 1 |
| BUZZI, A | 1 |
| CIBEIRA, JB | 1 |
| SCHOEN, H | 2 |
| KLEBANOV, BM | 1 |
| NEUMANN, J | 1 |
| MORELLI, AC | 1 |
| SLUTZKY, L | 1 |
| MENESESHOYOS, J | 1 |
| STUETTGEN, G | 1 |
| LEUTIGER, H | 1 |
| DEGREGORIO, G | 1 |
| BUDA, A | 1 |
| FIDECARO, A | 1 |
| VASTESAEGER, MM | 1 |
| KEDRA, M | 1 |
| MITURZYNSKA, H | 1 |
| TURAZZA, G | 1 |
| STOICHITA, M | 1 |
| VERDONK, G | 1 |
| LIPTON, P | 1 |
| MICHELS, JG | 1 |
| BODE, G | 1 |
| DANEMAN, EA | 1 |
| CHORNESKY, G | 1 |
| HAYCOX, JA | 1 |
| HUNTER, JD | 1 |
| WONG, LC | 1 |
| LUMISH, SH | 1 |
| BLYN, C | 1 |
| NODINE, JH | 1 |
| Wierzbicki, AS | 2 |
| RICHTER, IH | 1 |
| FOGEL, M | 1 |
| FABRICANT, H | 1 |
| Carlson, LA | 2 |
| Nicholls, S | 1 |
| Lundman, P | 1 |
| Meyers, CD | 1 |
| Kamanna, VS | 3 |
| Kashyap, ML | 4 |
| Benz, R | 1 |
| Suter, PM | 1 |
| Asano, M | 1 |
| Yamada, N | 1 |
| Foley, SM | 1 |
| Yeganeh, B | 1 |
| Moshtaghi-Kashanian, GR | 1 |
| Declercq, V | 1 |
| Moghadasian, MH | 1 |
| Amsterdam, EA | 1 |
| Dunbar, RL | 1 |
| Rader, DJ | 1 |
| Tavintharan, S | 2 |
| Lim, SC | 1 |
| Sum, CF | 1 |
| Blankenhorn, DH | 7 |
| Azen, SP | 4 |
| Nessim, SA | 4 |
| Criscuoli, M | 1 |
| Renzetti, AR | 1 |
| Subissi, A | 1 |
| Hotz, W | 1 |
| Henderson, LM | 1 |
| Pyrig, LA | 1 |
| Petrun, NM | 1 |
| Nikulina, GG | 1 |
| Gorelova, NR | 1 |
| Glueck, CJ | 2 |
| Holvoet, P | 1 |
| Collen, D | 1 |
| Kuo, PT | 1 |
| van der Wel, AM | 1 |
| Castro Cabezas, M | 1 |
| de Bruin, TW | 1 |
| Erkelens, DW | 1 |
| Oganov, RG | 1 |
| Kiseleva, NG | 1 |
| Aronov, DM | 2 |
| Akhmedzhanov, NM | 1 |
| Olfer'ev, AM | 1 |
| Kiseleva, NS | 1 |
| Perova, NV | 1 |
| Spinler, SA | 1 |
| Cziraky, MJ | 1 |
| Hodis, HN | 4 |
| Mack, WJ | 3 |
| Selzer, RH | 5 |
| Erickson, JK | 1 |
| Liu, CR | 2 |
| Liu, CH | 2 |
| Crawford, DW | 3 |
| Barth, JD | 1 |
| Alaupovic, P | 1 |
| Ayaori, M | 1 |
| Takahashi, Y | 1 |
| Franceschini, G | 1 |
| Paoletti, R | 1 |
| Dujovne, CA | 1 |
| Ziajka, PE | 1 |
| Wehmeier, T | 1 |
| Sinzinger, H | 1 |
| Saika, Y | 1 |
| Kodama, N | 1 |
| Kimura, K | 1 |
| Fujii, R | 1 |
| Ohtani, H | 1 |
| Mune, M | 1 |
| Mimura, K | 1 |
| Maeda, T | 1 |
| Yukawa, S | 1 |
| Zema, MJ | 1 |
| Guyton, JR | 1 |
| Xiang, M | 1 |
| Shircore, AM | 2 |
| Garg, R | 1 |
| Elam, MB | 1 |
| Crouse, JR | 1 |
| Davis, KB | 1 |
| Kennedy, JW | 1 |
| Egan, D | 1 |
| Herd, JA | 1 |
| Hunninghake, DB | 1 |
| Johnson, WC | 1 |
| Kostis, JB | 1 |
| Sheps, DS | 1 |
| Applegate, WB | 1 |
| Davidson, MH | 1 |
| Chin-Dusting, JP | 1 |
| Shaw, JA | 1 |
| Saucan, L | 1 |
| Brinton, EA | 1 |
| Sakai, T | 1 |
| Van, J | 1 |
| Ruhn, G | 2 |
| Scanu, AM | 1 |
| Geurian, K | 1 |
| Pinson, JB | 1 |
| Weart, CW | 1 |
| Sanmarco, ME | 2 |
| Wickham, EC | 1 |
| Luria, MH | 1 |
| Olsson, AG | 1 |
| Erikson, U | 1 |
| Kostner, GM | 1 |
| Rojo, JM | 1 |
| Portolés, MP | 1 |
| Ojeda, G | 1 |
| Portolés, A | 1 |
| Cashin-Hemphill, L | 1 |
| Spencer, CA | 1 |
| Nicoloff, JT | 1 |
| Chin, HP | 1 |
| Lee, NA | 1 |
| Kane, JP | 1 |
| Malloy, MJ | 1 |
| Johnson, RL | 1 |
| Cohen, L | 1 |
| Morgan, J | 1 |
| Davignon, J | 1 |
| Jacobsson, L | 1 |
| Roberts, L | 1 |
| West, R | 1 |
| Gibson, P | 1 |
| Lloyd, J | 1 |
| Postnikova, NV | 1 |
| Vasilenko, IuK | 1 |
| Cherevatyĭ, VS | 1 |
| Orbetsova, V | 1 |
| Iurukova, Ts | 1 |
| Kirov, T | 1 |
| Parker, F | 1 |
| Walldius, G | 1 |
| Wahlberg, G | 1 |
| Nagakawa, Y | 1 |
| Orimo, H | 1 |
| Harasawa, M | 1 |
| György, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000599] | Phase 3 | 0 participants | Interventional | 1980-06-30 | Completed | ||
| ARBITER 6: ARterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6 - HDL and LDL Treatment Strategies in Atherosclerosis (HALTS)[NCT00397657] | Phase 4 | 400 participants (Anticipated) | Interventional | 2006-11-30 | Terminated (stopped due to Independent steering committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns.) | ||
| [NCT00005696] | 0 participants | Observational | 1994-01-31 | Completed | |||
| [NCT00000539] | Phase 3 | 0 participants | Interventional | 1992-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
40 reviews available for niacin and Arteriosclerosis
| Article | Year |
|---|---|
Pharmaceutical initiatives to combat atherosclerosis--what to do with the good, the bad, and the ugly lipoproteins.
Topics: Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase In | 2002 |
The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers.
Topics: Arteriosclerosis; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Disease Progre | 2003 |
[SYNDROME OF OBLITERATION OF THE SUPRA-AORTIC TRUNKS (AORTIC ARCH SYNDROME)].
Topics: Adrenal Cortex Hormones; Anticoagulants; Aortic Aneurysm; Aortic Arch Syndromes; Aortic Diseases; Ar | 1963 |
DIETETIC AND PHARMACOLOGIC APPROACH TO ATHEROSCLEROSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Arteriosclerosis; Atherosclerosis; Cholesterol; Diet; Die | 1963 |
[DRUGS LOWERING THE CHOLESTEROL LEVEL IN THE BLOOD].
Topics: Antimetabolites; Arteriosclerosis; Ascorbic Acid; Cholesterol; Choline; Corrinoids; Ethyl Biscoumace | 1963 |
THE INTERRELATIONS BETWEEN CHOLESTEROL AND OTHER LIPIDS. II. A REVIEW.
Topics: Arteriosclerosis; Cholesterol; Edetic Acid; Estrogens; Fats, Unsaturated; Heparin; Humans; Hyperchol | 1964 |
New lipid-lowering agents.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Bile Acids and Salts; Cholesterol, HDL; Cholest | 2003 |
Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug.
Topics: Arteriosclerosis; Delayed-Action Preparations; Double-Blind Method; Fatty Acids, Nonesterified; Fema | 2004 |
The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol.
Topics: Animals; Arteriosclerosis; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; | 2004 |
Niacin therapy in atherosclerosis.
Topics: Anti-Inflammatory Agents; Arteriosclerosis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hu | 2004 |
[Low HDL-cholesterol, high triglycerides--well known but often ignored].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol, HDL; Clofibric A | 2004 |
[Dyslipidemia management in patients with impaired glucose tolerance].
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol, HDL; Clofibric Acid; Eicosapen | 2005 |
Update on risk factors for atherosclerosis: the role of inflammation and apolipoprotein E.
Topics: Apolipoproteins E; Arteriosclerosis; Cholestyramine Resin; Diet, Fat-Restricted; Exercise; Genotype; | 2005 |
Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
Topics: Arteriosclerosis; Cholesterol, HDL; Clofibric Acid; Coronary Artery Disease; Disease Progression; Hu | 2005 |
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.
Topics: Adipose Tissue; Arteriosclerosis; Coronary Disease; Fatty Acids, Nonesterified; Fibrinolysis; Flushi | 2005 |
Demystifying triglycerides: a practical approach for the clinician.
Topics: Arteriosclerosis; Clofibric Acid; Fish Oils; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; | 2005 |
Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?
Topics: Apoproteins; Arteriosclerosis; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, H | 2005 |
Nicotinic acid and its derivatives: a short survey.
Topics: Adipose Tissue; Animals; Arteriosclerosis; Biotransformation; Chemical Phenomena; Chemistry; Cyclic | 1983 |
Niacin.
Topics: Absorption; Arteriosclerosis; Biological Transport, Active; Diet; Humans; NAD; NADP; Niacin; Pellagr | 1983 |
Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
Topics: Arteriosclerosis; Cholesterol; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; | 1982 |
Lipid lowering and enhancement of fibrinolysis with niacin.
Topics: Arteriosclerosis; Cholesterol, LDL; Fibrinolysis; Humans; Lipids; Niacin | 1995 |
Dyslipidemia and coronary artery disease.
Topics: Arteriosclerosis; Cholesterol; Coronary Disease; Drug Therapy, Combination; Exercise; Gemfibrozil; H | 1994 |
[Triglycerides and atherosclerosis; treatment of hypertriglyceridemia].
Topics: Arteriosclerosis; Chylomicrons; Diet, Reducing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibito | 1994 |
Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Clinical Trials as Topic; Humans; Hydroxymethyl | 1994 |
Atherosclerosis--reversal with therapy.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Angiography; | 1993 |
[Progress in the treatment of atherosclerotic vascular diseases].
Topics: Angioplasty, Balloon, Coronary; Arteriosclerosis; Atherectomy; Diet; Humans; Ion Exchange Resins; Li | 1993 |
Drugs controlling triglyceride metabolism.
Topics: Anticholesteremic Agents; Arteriosclerosis; Fatty Acids, Omega-3; Humans; Hypertriglyceridemia; Metf | 1993 |
[The role of nicotinic acid in the treatment of atherosclerosis and atherogenic dyslipidemia].
Topics: Arteriosclerosis; Humans; Hyperlipidemias; Lipids; Niacin; Treatment Outcome | 1996 |
New lipid lowering drugs and new effects of old drugs.
Topics: Anticholesteremic Agents; Arteriosclerosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; | 1997 |
Peripheral neuropathy and lipid-lowering therapy.
Topics: Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Drug Therapy, Combination; Heptanoic Acids | 1998 |
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagu | 1998 |
Combination drug therapy for combined hyperlipidemia.
Topics: Arteriosclerosis; Drug Therapy, Combination; Fish Oils; Humans; Hyperlipidemias; Hypolipidemic Agent | 1999 |
Does differing metabolism by cytochrome p450 have clinical importance?
Topics: Anticoagulants; Arteriosclerosis; Calcium Channel Blockers; Cyclosporine; Cytochrome P-450 CYP3A; Cy | 2000 |
Mechanism of action of niacin on lipoprotein metabolism.
Topics: Apolipoproteins A; Apolipoproteins B; Arteriosclerosis; Humans; Lipoproteins, HDL; Lipoproteins, LDL | 2000 |
The benefits of niacin in atherosclerosis.
Topics: Arteriosclerosis; Cholesterol, HDL; Diabetes Mellitus; Humans; Niacin; Treatment Outcome | 2001 |
Lipids and atherosclerosis: clinical management of hypercholesterolaemia.
Topics: Arteriosclerosis; Cholestyramine Resin; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA | 2001 |
The triglyceride connection in atherosclerosis.
Topics: Alcohol Drinking; Arteriosclerosis; Coronary Disease; Diabetes Complications; Diet; Exercise; Humans | 1992 |
The affection of lipoprotein-a by lipid lowering drugs.
Topics: Arteriosclerosis; Bezafibrate; Cholestyramine Resin; Hormones; Humans; Hypolipidemic Agents; Lipopro | 1988 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; H | 1988 |
Developments leading to the metabolic role of vitamin B 6.
Topics: Acrodynia; Adult; Aged; Aging; Amines; Animals; Arteriosclerosis; Aspartate Aminotransferases; Biolo | 1971 |
12 trials available for niacin and Arteriosclerosis
| Article | Year |
|---|---|
Treatment of hyperlipidaemia and progression of atherosclerosis.
Topics: Adult; Arteriosclerosis; Colestipol; Double-Blind Method; Female; Humans; Hyperlipidemias; Middle Ag | 1983 |
[The use of Enduracin--a prolonged-action form of nicotinic acid--in correcting atherogenic dyslipidemias].
Topics: Adult; Aged; Arteriosclerosis; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; D | 1993 |
One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.
Topics: Adult; Arteriosclerosis; Carotid Arteries; Colestipol; Humans; Lipids; Longitudinal Studies; Male; M | 1993 |
One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.
Topics: Adult; Arteriosclerosis; Carotid Arteries; Colestipol; Humans; Lipids; Longitudinal Studies; Male; M | 1993 |
One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.
Topics: Adult; Arteriosclerosis; Carotid Arteries; Colestipol; Humans; Lipids; Longitudinal Studies; Male; M | 1993 |
One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.
Topics: Adult; Arteriosclerosis; Carotid Arteries; Colestipol; Humans; Lipids; Longitudinal Studies; Male; M | 1993 |
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.
Topics: Adult; Arteriosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Colestipol; Drug Therapy, | 1993 |
Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study.
Topics: Angiography; Arteriosclerosis; Carotid Arteries; Carotid Artery Injuries; Cholesterol, HDL; Choleste | 1995 |
Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Stu | 2000 |
Efficacy of two lipid-lowering treatments on quantitative coronary angiographic endpoints.
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Colestipol; Coronary Angiography; Drug Comb | 2000 |
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Arteriosclerosis; Aspirin; Cholesterol | 2000 |
Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Arteriosclerosis; Cholesterol, HDL; Dose-Response Relations | 2001 |
Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes.
Topics: Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Diabetic Angiopathies; Huma | 2002 |
Effects of colestipol-niacin therapy on human femoral atherosclerosis.
Topics: Arteriosclerosis; Cholesterol, Dietary; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Cor | 1991 |
The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results.
Topics: Adult; Angiography; Arteriosclerosis; California; Cholesterol, Dietary; Cholesterol, LDL; Clinical T | 1987 |
92 other studies available for niacin and Arteriosclerosis
| Article | Year |
|---|---|
Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Delayed-Action Preparations; Diabetes Mellitus; Do | 2002 |
Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model.
Topics: Animals; Arteriosclerosis; Cholesterol; Chromium; Cricetinae; Disease Models, Animal; Grape Seed Ext | 2002 |
Comparison of the effects of atorvastatin versus simvastatin on subclinical atherosclerosis in primary preventionas determined by electronbeam tomography.
Topics: Analysis of Variance; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Chi-Square Distribut | 2003 |
[Results in therapy of essential hypertension and cerebral sclerosis with mutan].
Topics: Arteriosclerosis; Brain; Essential Hypertension; Humans; Hypertension; Niacin; Nicotinic Acids; Tube | 1953 |
Treatment of arteriosclerosis and vague abdominal distress with niacinamide hydroiodide, without side-effects.
Topics: Arteriosclerosis; Gastrointestinal Diseases; Niacin; Niacinamide; Nicotinic Acids | 1955 |
The effect of nicotinic acid and pentylenetetrazol in the therapy of psychiatric symptoms of cerebral arteriosclerosis.
Topics: Arteriosclerosis; Humans; Intracranial Arteriosclerosis; Mental Disorders; Niacin; Nicotinic Acids; | 1954 |
[Therapy of cerebral sclerosis].
Topics: Arteriosclerosis; Humans; Niacin; Nicotinic Acids; Tuberous Sclerosis | 1957 |
[Combined iodine, sulfur and vitamins in therapy of arteriosclerotic disease].
Topics: Arteriosclerosis; Humans; Iodine; Methionine; Niacin; Nicotinic Acids; Sulfur; Vitamin A; Vitamin E; | 1957 |
Effect of niacin on the electroencephalogram of psychosis with cerebral arteriosclerosis.
Topics: Arteriosclerosis; Cholinergic Agents; Electroencephalography; Intracranial Arteriosclerosis; Niacin; | 1958 |
[Effect of nicotinic acid on blood lipids in arteriosclerosis].
Topics: Arteriosclerosis; Lipids; Niacin; Nicotinic Acids | 1957 |
A trial of oral metrazol and nicotinic acid in senile patients.
Topics: Arteriosclerosis; Brain; Niacin; Nicotinic Acids; Pentylenetetrazole | 1958 |
Effect of nicotinic acid on serum-lipids in normal and atherosclerotic subjects.
Topics: Arteriosclerosis; Humans; Lipids; Niacin; Nicotinic Acids | 1959 |
Evaluation of nicotinic acid as an hypocholesteremic and anti-atherogenic substance.
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Hematologic Diseases; Humans; Niacin; Nicotinic Acid | 1959 |
Influence of nicotinic acid on starvation hypercholesteremia in rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol; Hypercholesterolemia; Niacin; Nicotinic Acids; Rabbits; Star | 1961 |
[Studies of blood lipids in relation to atherosclerosis. The effect of nicotinic acid on the electrophoretic lipidogram in atherosclerosis].
Topics: Arteriosclerosis; Atherosclerosis; Humans; Lipids; Niacin; Nicotinic Acids | 1960 |
[Nicotinic acid therapy of arteriosclerosis and blood lipid disorders].
Topics: Arteriosclerosis; Lipid Metabolism Disorders; Lipids; Niacin; Nicotinic Acids | 1960 |
[Effect of nicotinic acid on experimental atheromatosis].
Topics: Arteriosclerosis; Atherosclerosis; Niacin; Nicotinic Acids | 1960 |
[The influence of an inositol-incotinic acid ester on the serum lipids of arteriosclerosis patients. Part 2].
Topics: Arteriosclerosis; Esters; Humans; Inositol; Lipids; Niacin; Nicotinic Acids | 1960 |
[Nicotinic acid treatment in hypercholesterolemia and atheromatosis].
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Hypercholesterolemia; Niacin; Nicotinic Acids | 1961 |
[Action of nicotinic acid on cholesterol and lipoproteins in atherosclerosis].
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Lipoproteins; Niacin; Nicotinic Acids | 1960 |
Some observations on the relationships between atherosclerosis, hyperlipemia, and D-thyroxine.
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Dextrothyroxine; Estrogens; Humans; Hyperlipidemias; | 1962 |
[The prophylaxis of atherosclerosis in occupational stress].
Topics: Arteriosclerosis; Atherosclerosis; Biomedical Research; Humans; Inositol; Lipids; Niacin; Nicotinic | 1962 |
Beneficial effects of vitamin A niacin and riboflavin in the management of certain types of vascular conditions.
Topics: Arteriosclerosis; Internal Medicine; Niacin; Nicotinic Acids; Raynaud Disease; Riboflavin; Thromboan | 1962 |
[Pharmacological properties of the preparation "Nikatol"].
Topics: Arteriosclerosis; Cholesterol; Coronary Disease; Humans; Niacin; Nicotinic Acids | 1963 |
[The effect of nicotinic acid on blood lipids in atherosclerosis].
Topics: Arteriosclerosis; Atherosclerosis; Humans; Lipids; Niacin; Nicotinic Acids | 1963 |
Reduction of plasma cholesterol levels in atherosclerosis by diet and drug treatment.
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Diet; Diet Therapy; Fats; Humans; Hypercholesterolem | 1963 |
[Nicotinic acid and associated drugs during the development of arteriosclerosis].
Topics: Arteriosclerosis; Niacin; Nicotinic Acids; Papaverine; Vitamin B 6 | 1962 |
[Anti-atherosclerotic action of vitamin A compounds, nicotinic acid, beta-pyridyl compounds and arachidonic acid].
Topics: Aorta; Arachidonic Acid; Arteriosclerosis; Humans; Niacin; Nicotinic Acids; Pyridines; Vitamin A | 1962 |
Effect of nicotinic acid and magnesium nicotinate on cholesterol-induced atherosclerosis in cockerels.
Topics: Animals; Arteriosclerosis; Atherosclerosis; Chickens; Cholesterol; Humans; Magnesium; Male; Niacin; | 1962 |
Observations on Benizol therapy in general practice. Ninety senile patients.
Topics: Arteriosclerosis; Dementia; General Practice; Geriatrics; Humans; Niacin; Nicotinic Acids; Pentylene | 1962 |
Concepts, theory and treatment of atherosclerosis.
Topics: Alcohols; Arteriosclerosis; Atherosclerosis; Fats, Unsaturated; Heparin; Hypercholesterolemia; Niaci | 1962 |
[Effect of Lipokapsul on the serum lipids in arteriosclerosis (with reference to different diet forms)].
Topics: Arteriosclerosis; Coronary Disease; Diet; Diet Therapy; Fatty Acids; Fatty Acids, Essential; Humans; | 1962 |
[INDIRECT FIBRINOLYSIS AS A THERAPEUTIC PRINCIPLE IN THE TREATMENT OF ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Fibrinolysis; Inositol; Niacin; Nicotinic Acids; Phospholipids; S | 1963 |
ANTI-ATHEROGENIC EFFECTS OF ALUMINUM NICOTINATE IN THE HYPERCHOLESTEROLEMIC CANINE.
Topics: Aluminum; Aluminum Compounds; Animals; Arteriosclerosis; Atherosclerosis; Dogs; Hypercholesterolemia | 1963 |
[ATHEROSCLEROSIS. RECENT ASPECTS OF ITS BIOCHEMISTRY, PATHOGENESIS AND CLINICAL FEATURES AND OF THE ACTION OF SOME HYPOCHOLESTEREMIC DRUGS].
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Diet; Diet Therapy; Fatty Acids; Lipid Metabolism; L | 1963 |
[TRIPARANOL, L-TRIIODOTHYRONINE AND 3-PYRIDYL ACETIC ACID IN THE CONTROL OF CHOLESTEROLEMIA. A COMPARATIVE STUDY].
Topics: Acetates; Acetic Acid; Arteriosclerosis; Hypercholesterolemia; Niacin; Nicotinic Acids; Triiodothyro | 1963 |
A LONG TERM STUDY OF THE EFFECT OF NICOTINIC ACID MEDICATION ON HYPERCHOLESTEREMIA.
Topics: Acanthosis Nigricans; Arteriosclerosis; Coronary Disease; Diabetes Mellitus; Geriatrics; Humans; Hyp | 1963 |
[FINDINGS ON THE HYPOLIPEMIZING AND HYPOCHOLESTEROLEMIZING ACTION OF A NEW PHARMACOLOGIC ASSOCIATION].
Topics: Arteriosclerosis; Cholesterol; Fatty Acids; Lipids; Niacin; Nicotinic Acids; Pyridoxine; Rutin; Vita | 1963 |
[USE OF NICOTINIC ACID IN ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Blood Protein Electrophoresis; Cholesterol; Lecithins; Niacin; Ni | 1963 |
[PROBLEMS IN DRUG THERAPY AND ATHEROSCLEROSIS PREVENTION].
Topics: Arteriosclerosis; Atherosclerosis; Choline; Fatty Acids; Folic Acid; Hematinics; Humans; Lipid Metab | 1963 |
[ACTIVATION OF FIBRINOLYSIS BY THE PROLONGED ORAL ADMINISTRATION OF A NICOTINIC DERIVATIVE IN ARTERIOSCLEROTIC SUBJECTS].
Topics: Administration, Oral; Arteriosclerosis; Blood Pressure; Blood Proteins; Cholesterol; Fibrinolysin; F | 1963 |
[7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
Topics: Arteriosclerosis; Arteriosclerosis Obliterans; Cholesterol; Coronary Disease; Humans; Intracranial A | 1963 |
[STUDY ON THE CHEMOTHERAPY OF ARTERIOSCLEROSIS].
Topics: Arteriosclerosis; Cholagogues and Choleretics; Dextrans; Fatty Acids; Heparinoids; Linoleic Acid; Li | 1964 |
[SODIUM CITRATE IN ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Citrates; Injections, Intramuscular; Injections, Int | 1963 |
[THE USE OF DRUGS IN THE CONTROL OF CHOLESTEROLEMIA].
Topics: Arteriosclerosis; Diet; Hypercholesterolemia; Niacin; Nicotinic Acids; Thyroxine; Toxicology; Triiod | 1963 |
[TREATMENT OF THE CUTANEOUS ISCHEMIA OF OCCLUSIVE ARTERIOSCLEROSIS OF THE EXTREMITIES WITH A VASODILATING PREPARATION OF LOCAL ACTION].
Topics: Amputees; Arteriosclerosis; Arteriosclerosis Obliterans; Body Temperature; Diabetes Mellitus; Humans | 1963 |
[THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
Topics: Arteriosclerosis; Atherosclerosis; Dietary Fats; Glycerides; Heparin; Heparinoids; Hypercholesterole | 1963 |
[PHARMACOLOGICAL STUDIES ON THE PREPARATION "NICATOL"].
Topics: Arteriosclerosis; Blood Proteins; Cholesterol; Hypercholesterolemia; Lecithins; Lipids; Lipoproteins | 1963 |
[STUDIES ON THE INFLUENCING OF FAT CLEARANCE IN VIVO].
Topics: Adenosine Triphosphate; Arteriosclerosis; Dietary Fats; Heparin; Hyperlipidemias; Hypertension; Iodi | 1964 |
[ELEVATION OF THE DEPRESSED THROMBOLYTIC ACTIVITY, IN ARTERIOSCLEROTICS SUBJECTED TO PROLONGED ORAL ANTICOAGULANT THERAPY, USING A DERIVATIVE OF NICOTINIC ACID].
Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Arteriosclerosis; Blood Coagulation Tests; Cholin | 1963 |
[CONCOMITANCE OF HYPERGLYCEMIA WITH THE USE OF NICOTINIC ACID IN LARGE DOSES. STUDY IN DIABETICS].
Topics: Arteriosclerosis; Body Weight; Cholesterol; Diabetes Mellitus; Hyperglycemia; Lipid Metabolism; Niac | 1963 |
[ATHEROSCLEROSIS AND CHOLESTEROLEMIA].
Topics: Arteriosclerosis; Atherosclerosis; Enzyme Inhibitors; Estrogens; Fats, Unsaturated; Heparin; Hyperch | 1963 |
[DRUGS AGAINST HYPERCHOLESTEROLEMIA].
Topics: Adrenal Cortex Hormones; Arteriosclerosis; Estrogens; Gonadal Steroid Hormones; Heparin; Humans; Hyp | 1964 |
[ON CHOLESTEROL MOBILIZATION IN THE TREATMENT OF XANTHOMA AND ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Drug Therapy; Heparin; Humans; Hypercholesterolemia; | 1963 |
[COMPARATIVE ANALYSIS OF THE VASCULAR EFFECTS OF 3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL-THEOPHYLLINE NICOTINATE, NICOTINIC ACID AND THEOPHYLLINE].
Topics: Arteriosclerosis; Biomedical Research; Blood Circulation; Cerebrovascular Circulation; Cerebrovascul | 1964 |
[BLOOD LIPIDS IN ATHEROSCLEROSIS AND THE ACTION OF SOME AGENTS MODIFYING LIPEMIA].
Topics: Androsterone; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Butyrates; Cholesterol; D | 1964 |
[THE EFFECT OF NICOTINIC ACID ON THE METABOLISM OF LIPIDS, ESPECIALLY THE BLOOD CHOLESTEROL IN CASES OF ARTERIOSCLEROSIS].
Topics: Arteriosclerosis; Biomedical Research; Blood Chemical Analysis; Blood Proteins; Cholesterol; Coronar | 1964 |
[BETAIN NICOTINATE IN PROLONGED ORAL FIBRINOLYTIC THERAPY].
Topics: Alkaloids; Arteriosclerosis; Dosage Forms; Drug Therapy; Fibrinolysis; Geriatrics; Injections; Injec | 1964 |
[FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT].
Topics: Anticoagulants; Arteriosclerosis; Deoxyribonuclease I; Drug Therapy; Fibrinolysis; Inflammation; Nia | 1964 |
THE INFLUENCE OF NUTRITIONAL AND PHARMACOLOGICAL FACTORS ON THE BLOOD LIPID PATTERN IN ATHEROSCLEROTIC DISEASE AND IN THE TREATMENT OF PEPTIC ULCER.
Topics: Androgens; Anticholesteremic Agents; Arteriosclerosis; Dextrothyroxine; Diet; Diet Therapy; Dietary | 1964 |
THE EFFECTS OF NICOTINIC ACID ON RABBIT HYPERCHOLESTEROLEMIA AND ATHEROGENESIS.
Topics: Aorta; Arteriosclerosis; Atherosclerosis; Blood Chemical Analysis; Cholesterol; Diet; Hypercholester | 1965 |
[NEW POSSIBILITIES IN THE DIAGNOSIS AND MEASURES FOR DRUG CONTROL OF DEGENERATIVE VASCULAR DISEASES].
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Chemical Analysis; Cardiovascular Diseases; Corona | 1964 |
Psychosomatic investigations of cerebral arteriosclerosis with psychosis.
Topics: Arteriosclerosis; Humans; Intracranial Arteriosclerosis; Niacin; Nicotinic Acids; Psychosomatic Medi | 1955 |
Nicotinic acid effect on cockerels. Cholesterol and atheroma lesions.
Topics: Animals; Arteriosclerosis; Chickens; Cholesterol; Humans; Male; Niacin; Nicotinic Acids; Plaque, Ath | 1961 |
Inositol niacinate as a peripheral vasodilator.
Topics: Arteriosclerosis; Cardiovascular Agents; Humans; Inositol; Niacin; Nicotinic Acids; Vasodilator Agen | 1962 |
An evaluation of roniacol tartrate in arteriosclerosis obliterans.
Topics: Arteriosclerosis; Arteriosclerosis Obliterans; Humans; Niacin; Nicotinic Acids; Nicotinyl Alcohol; T | 1951 |
Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, HDL; Diet; Feno | 2005 |
Benefit on atherosclerosis of adding niacin in patients with low HDL-cholesterol taking a statin.
Topics: Arteriosclerosis; Cholesterol, LDL; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Red | 2005 |
Glunicate (LG 13979) protects the arterial wall from cholesterol-induced atherosclerotic changes in the rabbit without affecting plasma lipids.
Topics: Animals; Aorta; Arteriosclerosis; Blood Coagulation; Cholesterol, Dietary; Dose-Response Relationshi | 1984 |
Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis.
Topics: Adolescent; Adult; Arteriosclerosis; Clofibrate; Dipyridamole; Female; Glomerulonephritis; Humans; H | 1984 |
[The treatment of atherosclerosis--drug therapy].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Cholestyramine Resin; Humans; Middle Aged; | 1993 |
[Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol].
Topics: Arteriosclerosis; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoprotein(a); Niacin; Nic | 1999 |
Choice of lipid-regulating drugs.
Topics: Apolipoproteins; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Drug Intera | 2001 |
Lp A-I and niacin: new views of an antiatherogenic duo.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Arteriosclerosis; Cholesterol, HDL; Hepatocytes; Humans; Hy | 2001 |
Relation between arteriographically diagnosed femoral atherosclerosis and serum lipids. Prevalence and treatment in hyperlipidaemic subjects.
Topics: Adult; Aged; Aorta, Abdominal; Aortic Aneurysm; Arteriosclerosis; Drug Therapy, Combination; Femoral | 1992 |
Lp(a): a link between thrombosis and atherosclerosis.
Topics: Adult; Arteriosclerosis; Child; Fatty Acids, Omega-3; Humans; Hyperlipoproteinemias; Hypolipidemic A | 1992 |
Atherosclerosis: the importance of HDL cholesterol and prostacyclin: a role for niacin therapy.
Topics: Animals; Arteriosclerosis; Cholesterol, HDL; Epoprostenol; Humans; Niacin | 1990 |
The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled study.
Topics: Adult; Analysis of Variance; Arteriosclerosis; Blood Pressure; Cholesterol, VLDL; Combined Modality | 1990 |
Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: therapeutic approaches to prevention of atherosclerosis.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Arteriosclerosis; Body Weight; Cholesterol, H | 1985 |
Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes.
Topics: Anaphylaxis; Animals; Antibody Formation; Antigen-Antibody Complex; Arteriosclerosis; Clofibrate; Cl | 1985 |
Alterations in serum thyroid hormonal indices with colestipol-niacin therapy.
Topics: Adult; Arteriosclerosis; Colestipol; Drug Therapy, Combination; Humans; Lipids; Male; Middle Aged; N | 1987 |
Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol.
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Combined Modality Therapy; Drug Therapy, Combination; Fe | 1988 |
Medical management of hyperlipidemia and the role of probucol.
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gem | 1986 |
[Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs].
Topics: Animals; Arteries; Arteriosclerosis; Cholesterol; Hypercholesterolemia; Hyperlipoproteinemias; Hypol | 1986 |
Study bolsters case against cholesterol.
Topics: Adult; Arteriosclerosis; Cholesterol; Colestipol; Dietary Fats; Humans; Male; Middle Aged; Niacin | 1987 |
Treatment of homozygous familial hypercholesterolaemia: an informative sibship.
Topics: Adolescent; Age Factors; Arteriosclerosis; Cholestyramine Resin; Clofibrate; Female; Homozygote; Hum | 1985 |
[Changes in lysozyme activity in hyperlipidemia and atherosclerosis in animals].
Topics: Adjuvants, Immunologic; Animals; Arteriosclerosis; Enzyme Activation; Hypercholesterolemia; Hyperlip | 1985 |
[Regression of experimental cholesterol-induced atherosclerosis in rabbits after stopping the atherogenic diet and after treatment with nicotinic acid].
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol, Dietary; Diet, Atherogenic; Lipid Metabolism; Liver; | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyr | 1985 |
Effects of nicotinic acid and its derivatives on lipid metabolism and other metabolic factors related to atherosclerosis.
Topics: Animals; Apolipoproteins; Arteriosclerosis; Bile Acids and Salts; Carbohydrate Metabolism; Cholester | 1985 |
The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.
Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis; Blood Platelets; Cholesterol; Collagen; Female | 1985 |
[Skin manifestation of internal diseases].
Topics: Adjustment Disorders; Adolescent; Adult; Arteriosclerosis; Child; Female; Humans; Hypertension; Lupu | 1979 |